CoChat
Sign Up
Cited by 86

The role of miR-103 and miR-107 in regulation of CDK5R1 expression and in cellular migration

Moncini, Silvia, Salvi, Alessandro, Zuccotti, Paola, Viero, Gabriella, Quattrone, Alessandro, Barlati, Sergio, De Petro, Giuseppina, Venturin, Marco +1 more·2011·PLoS ONE
DOI 10.1371/journal.pone.0020038PMC PMC3100319
Open this paper in CoChat — free account

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0020038

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 56

  1. [1]Humbert S Dhavan R Tsai L 2000 p39 activates cdk5 in neurons, and is associated with the actin cytoskeleton. J Cell Sci 113 975 983 10683146
  2. [2]Uchida T Ishiguro K Ohnuma J Takamatsu M Yonekura S 1994 Precursor of cdk5 activator, the 23 kDa subunit of tau protein kinase II: its sequence and developmental change in brain. FEBS Lett 355 35 40 7957957
  3. [3]Jeong YG Rosales JL Marzban H Sillitoe RV Park DG 2003 The cyclin-dependent kinase 5 activator, p39, is expressed in stripes in the mouse cerebellum. Neuroscience 118 323 334 12699769
  4. [4]Song JH Wang CX Song DK Wang P Shuaib A 2005 Interferon gamma induces neurite outgrowth by up-regulation of p35 neuron-specific cyclin-dependent kinase 5 activator via activation of ERK1/2 pathway. J Biol Chem 280 12896 12901 15695523
  5. [5]Namgung U Choi B Lee J Jun S Kim KT 2004 Activation of cyclin-dependent kinase 5 (Cdk5) is involved in axonal regeneration. Mol Cell Neurosci 25 422 432 15033170
  6. [6]Weishaupt JH Neusch C Bähr M 2003 Cyclin-dependent kinase 5 (CDK5) and neuronal cell death. Cell Tissue Res 312 1 8 12684868
  7. [7]Angelo M Plattner F Giese KP 2006 Cyclin-dependent kinase 5 in synaptic plasticity, learning and memory. J Neurochem 99 353 370 17029592
  8. [8]Paglini G Peris L Diez-Guerra J Quiroga S Caceres A 2001 The Cdk5-p35 kinase associates with the Golgi apparatus and regulates membrane traffic. EMBO Rep 2 1139 1144 11743029 PMC1084168
  9. [9]Dhavan R Tsai LH 2001 A decade of CDK5. Nat Rev Mol Cell Biol 2 749 759 11584302
  10. [10]Ohshima T Ward JM Huh CG Longenecker G Veeranna 1996 Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death. Proc Natl Acad Sci USA 93 11173 11178 8855328 PMC38303
  11. [11]Chae T Kwon YT Bronson R Dikkes P Li E 1997 Mice lacking p35, a neuronal specific activator of Cdk5, display cortical lamination defects, seizures, and adult lethality. Neuron 18 29 42 9010203
  12. [12]Patrick GN Zukerberg L Nikolic M de la Monte S Dikkes P 1999 Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 402 615 622 10604467
  13. [13]Lau LF Seymour PA Sanner MA Schachter JB 2002 Cdk5 as a drug target for the treatment of Alzheimer's disease. J Mol Neurosci 19 267 273 12540052
  14. [14]Smith PD Crocker SJ Jackson-Lewis V Jordan-Sciutto KL Hayley S 2003 Cyclin-dependent kinase 5 is a mediator of dopaminergic neuron loss in a mouse model of Parkinson's disease. Proc Natl Acad Sci U S A 100 13650 13655 14595022 PMC263868
  15. [15]Nguyen MD Lariviere RC Julien JP 2001 Deregulation of Cdk5 in a mouse model of ALS: toxicity alleviated by perikaryal neurofilament inclusions. Neuron 30 135 147 11343650
  16. [16]Venturin M Guarnieri P Natacci F Stabile M Tenconi R 2004 Mental retardation and cardiovascular malformations in NF1 microdeleted patients point to candidate genes in 17q11.2. J Med Genet 41 35 41 14729829 PMC1757270
  17. [17]Takahashi S Ohshima T Cho A Sreenath T Iadarola MJ 2005 Increased activity of cyclin-dependent kinase 5 leads to attenuation of cocaine-mediated dopamine signaling. Proc Natl Acad Sci U S A 102 1737 1742 15665076 PMC547862
  18. [18]Utreras E Futatsugi A Rudrabhatla P Keller J Iadarola MJ 2009 Tumor necrosis factor-alpha regulates cyclin-dependent kinase 5 activity during pain signaling through transcriptional activation of p35. J Biol Chem 284 2275 2284 19049962 PMC2629110
  19. [19]Quintanilla RA Orellana DI González-Billault C Maccioni RB 2004 Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5/p35 pathway. Exp Cell Res 295 245 257 15051507
  20. [20]Song JH Wang CX Song DK Wang P Shuaib A 2005 Interferon gamma induces neurite outgrowth by up-regulation of p35 neuron-specific cyclin-dependent kinase 5 activator via activation of ERK1/2 pathway. J Biol Chem 280 12896 12901 15695523
  21. [21]Patrick GN Zhou P Kwon YT Howley PM Tsai LH 1998 p35, the neuronal-specific activator of cyclin-dependent kinase 5 (Cdk5) is degraded by the ubiquitin-proteasome pathway. J Biol Chem 273 24057 24064 9727024
  22. [22]Zhao CT Li K Li JT Zheng W Liang XJ 2009 PKCdelta regulates cortical radial migration by stabilizing the Cdk5 activator p35. Proc Natl Acad Sci U S A 106 21353 21358 19965374 PMC2781735
  23. [23]Moncini S Bevilacqua A Venturin M Fallini C Ratti A 2007 The 3′ untranslated region of human Cyclin-Dependent Kinase 5 Regulatory subunit 1 contains regulatory elements affecting transcript stability. BMC Mol Biol 8 111 18053171 PMC2222623
  24. [24]Mobarak CD Anderson KD Morin M Beckel-Mitchener A Rogers SL 2000 The RNA-binding protein HuD is required for GAP-43 mRNA stability, GAP-43 gene expression, and PKC-dependent neurite outgrowth in PC12 cells. Mol Biol Cell 11 3191 3203 10982410 PMC14985
  25. [25]Szaro BG Strong MJ 2010 Post-transcriptional control of neurofilaments: New roles in development, regeneration and neurodegenerative disease. Trends Neurosci 33 27 37 19906448
  26. [26]Bai Y Lu H Machida CA 2006 CRM 1-mediated degradation and agonist-induced down-regulation of beta-adrenergic receptor mRNAs. Biochim Biophys Acta 1763 1076 1089 16997396 PMC1896136
  27. [27]Westmark PR Shin HC Westmark CJ Soltaninassab SR Reinke EK 2006 Decoy mRNAs reduce beta-amyloid precursor protein mRNA in neuronal cells. Neurobiol Aging 27 787 796 16672170
  28. [28]Maes OC Chertkow HM Wang E Schipper HM 2009 MicroRNA: Implications for Alzheimer Disease and other Human CNS Disorders. Curr Genomics 10 154 168 19881909 PMC2705849
  29. [29]Doench JG Sharp PA 2004 Specificity of microRNA target selection in translational repression. Genes Dev 18 504 511 15014042 PMC374233
  30. [30]Lewis BP Burge CB Bartel DP 2005 Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120 15 20 15652477
  31. [31]Wang Y Medvid R Melton C Jaenisch R Blelloch R 2007 DGCR8 is essential for microRNA biogenesis and silencing of embryonic stem cell self-renewal. Nat Genet 39 380 385 17259983 PMC3008549
  32. [33]Dostie J Mourelatos Z Yang M Sharma A Dreyfuss G 2003 Numerous microRNPs in neuronal cells containing novel microRNAs. RNA 9 180 186 12554860 PMC1370383
  33. [34]Kosik KS 2006 The neuronal microRNA system. Nat Rev Neurosci 7 911 920 17115073
  34. [35]Bushati N Cohen SM 2008 MicroRNAs in neurodegeneration. Curr Opin Neurobiol 18 292 296 18662781
  35. [36]Zeng Y Cullen BR 2003 Sequence requirements for micro RNA processing and function in human cells. RNA 9 112 123 12554881 PMC1370375
  36. [37]Kuss AW Chen W 2008 MicroRNAs in brain function and disease. Curr Neurol Neurosci Rep 8 190 197 18541114
  37. [38]Finnerty JR Wang WX Hébert SS Wilfred BR Mao G 2010 The miR-15/107 group of microRNA genes: evolutionary biology, cellular functions, and roles in human diseases. J Mol Biol 402 491 509 20678503 PMC2978331
  38. [39]Babak T Zhang W Morris Q Blencowe BJ Hughes TR 2004 Probing microRNAs with microarrays: tissue specificity and functional inference. Rna 10 1813 1819 15496526 PMC1370668
  39. [40]Baskerville S Bartel DP 2005 Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. Rna 11 241 247 15701730 PMC1370713
  40. [41]Esau C Kang X Peralta E Hanson E Marcusson EG 2004 MicroRNA-143 regulates adipocyte differentiation. J Biol Chem 279 52361 52365 15504739
  41. [42]Miska EA Alvarez-Saavedra E Townsend M Yoshii A Sestan N 2004 Microarray analysis of microRNA expression in the developing mammalian brain. Genome Biol 5 R68 15345052 PMC522875
  42. [43]Roldo C Missiaglia E Hagan JP Falconi M Capelli P 2006 MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J Clin Oncol 24 4677 4684 16966691
  43. [45]Marsit CJ Eddy K Kelsey KT 2006 MicroRNA responses to cellular stress. Cancer Res 66 10843 10848 17108120
  44. [46]van Rooij E Sutherland LB Liu N Williams AH McAnally J 2006 A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci U S A 103 18255 18260 17108080 PMC1838739
  45. [47]Wang WX Rajeev BW Stromberg AJ Ren N Tang G 2008 The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. J Neurosci 28 1213 1223 18234899 PMC2837363
  46. [48]Lee KH Lotterman C Karikari C Omura N Feldmann G 2009 Epigenetic silencing of MicroRNA miR-107 regulates cyclin-dependent kinase 6 expression in pancreatic cancer. Pancreatology 9 293 301 19407485 PMC2835374
  47. [49]Wang WX Wilfred BR Madathil SK Tang G Hu Y 2010 miR-107 regulates granulin/progranulin with implications for traumatic brain injury and neurodegenerative disease. Am J Pathol 177 334 345 20489155 PMC2893676
  48. [50]Li X Zhang Y Shi Y Dong G Liang J 2010 MicroRNA-107, an Oncogene MicroRNA that Regulates Tumor Invasion and Metastasis By Targeting DICER1 in Gastric Cancer: MiR-107 promotes gastric cancer invasion and metastasis. J Cell Mol Med doi: 10.1111/j.1582-4934.2010.01194.x PMC3918045 21029372 · DOI
  49. [51]Mellios N Huang HS Grigorenko A Rogaev E Akbarian S 2008 A set of differentially expressed miRNAs, including miR-30a-5p, act as post-transcriptional inhibitors of BDNF in prefrontal cortex. Hum Mol Genet 17 3030 3042 18632683 PMC2722882
  50. [52]Zhang C 2009 Novel functions for small RNA molecules. Curr Opin Mol Ther 11 641 651 20072941 PMC3593927
  51. [53]Feng Y Walsh CA 2001 Protein-protein interactions, cytoskeletal regulation and neuronal migration. Nat Rev Neurosci 2 408 416 11389474
  52. [54]Venturin M Moncini S Villa V Russo S Bonati MT 2006 Mutations and novel polymorphisms in coding regions and UTRs of CDK5R1 and OMG genes in patients with non-syndromic mental retardation. Neurogenetics 7 59 66 16425041
  53. [55]Lau P de Strooper B 2010 Dysregulated microRNAs in neurodegenerative disorders. Semin Cell Dev Biol 21 768 773 20080199
  54. [56]Anderton BH Betts J Blackstock WP Brion JP Chapman S 2001 Sites of phosphorylation in tau and factors affecting their regulation. Biochem Soc Symp 67 73 80 11447841
  55. [57]Ahlijanian MK Barrezueta NX Williams RD Jakowski A Kowsz KP 2000 Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5. Proc Natl Acad Sci U S A 97 2910 2915 10706614 PMC16029
  56. [58]Salvi A Sabelli C Moncini S Venturin M Arici B 2009 MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells. FEBS J 276 2966 2982 19490101

Cited by

Sorted by citations

Authors
Moncini, S., Salvi, A., Zuccotti, P., Viero, G., Quattrone, A., Barlati, S., De Petro, G., Venturin, M., & Riva, P.
Venue
PLoS ONE
Publisher
Public Library of Science (PLoS)
Published
2011-05-23
Volume
6
Issue
5
Pages
e20038
ISSN
1932-6203
DOI
10.1371/journal.pone.0020038
PMC
PMC3100319
Cited by
86
References
2
Language
en
Licence
creativecommons.org/licenses/by/4.0/ (unspecified)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review